{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:57:00Z","timestamp":1790485020502,"version":"4.1.0"},"reference-count":84,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T00:00:00Z","timestamp":1646352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccines"],"abstract":"<jats:p>Vaccination against infectious diseases is a cornerstone of veterinary medicine in the prevention of disease transmission, illness severity, and often death in animals. In North American equine medicine, equine vaccines protecting against tetanus, rabies, Eastern and Western equine encephalomyelitis, and West Nile are core vaccines as these have been classified as having a heightened risk of mortality, infectiousness, and endemic status. Some guidelines differ from the label of vaccines, to improve the protection of patients or to decrease the unnecessary administration to reduce potential side effects. In North America, resources for the equine practitioners are available on the American Association of Equine Practitioners (AAEP) website. Conversely, in small companion animals, peer review materials are regularly published in open access journals to guide the vaccination of dogs and cats. The aims of this review are to present how the vaccine guidelines have been established for small companion animals and horses in North America, to review the equine literature to solidify or contrast the current AAEP guidelines of core vaccines, and to suggest future research directions in the equine vaccine field considering small companion animal strategies and the current available resources in equine literature.<\/jats:p>","DOI":"10.3390\/vaccines10030398","type":"journal-article","created":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T20:40:38Z","timestamp":1646599238000},"page":"398","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Equids\u2019 Core Vaccines Guidelines in North America: Considerations and Prospective"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-8450-188X","authenticated-orcid":false,"given":"H\u00e9l\u00e8ne","family":"Desanti-Consoli","sequence":"first","affiliation":[{"name":"DoctoraDesanti, San Jose 11801, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Bouillon","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre, Saint Kitts and Nevis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-7710","authenticated-orcid":false,"given":"Ronan J. J.","family":"Chapuis","sequence":"additional","affiliation":[{"name":"Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre, Saint Kitts and Nevis"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"340","DOI":"10.3389\/fvets.2021.654289","article-title":"Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines","volume":"8","author":"Aida","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Cohen, N.D., and Bordin, A.I. (2015). Principles of vaccination. Equine Clinical Immunology, John Wiley & Sons, Inc.","DOI":"10.1002\/9781119086512.ch28"},{"key":"ref_3","unstructured":"Wilson, J. (2005, January 3\u20137). Vaccine efficacy and controversies. Proceedings of the 51st Annual Convention of the American Association of Equine Practitioners, Seattle, WA, USA."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jevs.2018.12.004","article-title":"Reactive Seizures After Vaccination in a Thoroughbred Broodmare","volume":"73","author":"Barros","year":"2019","journal-title":"J. Equine Vet. Sci."},{"key":"ref_5","unstructured":"American Association of Equine Practitioners (AAEP) (2021, December 26). Vaccination Guidelines. Available online: https:\/\/aaep.org\/guidelines\/vaccination-guidelines."},{"key":"ref_6","unstructured":"Wilson, W. (2005, January 3\u20137). Strategies for vaccinating mares, foals, and weanlings. Proceedings of the 51st Annual Convention of the American Association of Equine Practitioners, Seattle, WA, USA."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.5326\/JAAHA-MS-7123","article-title":"2020 AAHA\/AAFP feline vaccination guidelines","volume":"56","author":"Stone","year":"2020","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.5326\/JAAHA-MS-6741","article-title":"2017 AAHA canine vaccination guidelines","volume":"53","author":"Ford","year":"2017","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_9","first-page":"332","article-title":"Canine and feline immunization guidelines\u20141982","volume":"181","author":"Bittle","year":"1982","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_10","first-page":"26","article-title":"Revaccination guidelines revisited","volume":"41","author":"Gumley","year":"2000","journal-title":"Can. Vet. J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2460\/javma.2002.221.1401","article-title":"AVMA Council on Biologic and Therapeutic Agents\u2019 report on cat and dog vaccines","volume":"221","author":"Klingborg","year":"2002","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_12","unstructured":"American Veterinary Medical Association (2021, December 26). Vaccination Principles. Available online: https:\/\/www.avma.org\/resources-tools\/avma-policies\/vaccination-principles."},{"key":"ref_13","first-page":"119","article-title":"Report of the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: Executive summary and 2003 canine vaccine guidelines and recommendations","volume":"39","author":"Paul","year":"2003","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/jsap.2_12431","article-title":"WSAVA guidelines for the vaccination of dogs and cats","volume":"57","author":"Day","year":"2016","journal-title":"J. Small Anim. Pract."},{"key":"ref_15","unstructured":"American Animal Hospital Association (AAHA) (2021, December 26). Lifestyle-Based Vaccine Calculator. Available online: https:\/\/www.aaha.org\/aaha-guidelines\/2020-aahaaafp-feline-vaccination-guidelines\/feline-vaccine-calculator\/."},{"key":"ref_16","unstructured":"Sellon, D.C., and Long, M.T. (2013). Immunoprophylaxis. Equine Infectious Diseases, Elsevier Health Sciences. [2nd ed.]."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2460\/javma.238.6.741","article-title":"Evaluation of the safety of vaccinating mares against equine viral arteritis during mid or late gestation or during the immediate postpartum period","volume":"238","author":"Broaddus","year":"2011","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"247218","DOI":"10.1155\/2014\/247218","article-title":"Methodological issues and evidence of malfeasance in research purporting to show Thimerosal in vaccines is safe","volume":"2014","author":"Hooker","year":"2014","journal-title":"BioMed Res. Int."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/evj.12350","article-title":"Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days","volume":"47","author":"Davis","year":"2015","journal-title":"Equine Vet. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1136\/vr.164.25.783","article-title":"Effects of administration of an avirulent live vaccine of Lawsonia intracellularis on mares and foals","volume":"164","author":"Pusterla","year":"2009","journal-title":"Vet. Rec."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.vetmic.2004.09.006","article-title":"Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine","volume":"104","author":"Cauchard","year":"2004","journal-title":"Vet. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.2042-3306.1991.tb04752.x","article-title":"Failure of passive immunisation by colostrum from immunised mares to protect foals against Rhodococcus equi pneumonia","volume":"23","author":"Martens","year":"1991","journal-title":"Equine Vet. J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jevs.2010.05.008","article-title":"Vaccination response of young foals to keyhole limpet hemocyanin: Evidence of effective priming in the presence of maternal antibodies","volume":"30","author":"Sturgill","year":"2010","journal-title":"J. Equine Vet. Sci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/CVI.00328-10","article-title":"Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses","volume":"17","author":"Ryan","year":"2010","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.2746\/042516401776249435","article-title":"Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination","volume":"33","author":"Wilson","year":"2001","journal-title":"Equine Vet. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/tvjl.2000.0546","article-title":"Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings","volume":"161","author":"Cullinane","year":"2001","journal-title":"Vet. J."},{"key":"ref_27","unstructured":"Wilson, W.D. (1999, January 5\u20138). Vaccination programs for goals and weanlings. Proceedings of the 45th Annual Convention, Albuquerque, NM, USA."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.jcpa.2009.10.010","article-title":"The effect of age on the immune response of horses to vaccination","volume":"142","author":"Muirhead","year":"2010","journal-title":"J. Comp. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1939-1676.2008.0091.x","article-title":"The effect of age on serum antibody titers after rabies and influenza vaccination in healthy horses","volume":"22","author":"Muirhead","year":"2008","journal-title":"J. Vet. Intern. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cveq.2010.12.007","article-title":"Equine pituitary pars intermedia dysfunction","volume":"27","author":"McFarlane","year":"2011","journal-title":"Vet. Clin. Equine Pract."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"469","DOI":"10.21836\/PEM20150506","article-title":"Immunization strategies and seroprotection against tetanus in horses in central Germany","volume":"31","author":"Recknagel","year":"2015","journal-title":"Pferdeheilkunde"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Kay, G., Souhail, M., and Mazan, M. (2021). Recurrent tetanus in a donkey. Equine Vet. Educ.","DOI":"10.1111\/eve.13580"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Wilson, W.D. (2017). Assessment of Vaccination Status and Susceptibility to Infection. Interpretation of Equine Laboratory Diagnostics, John Wiley & Sons.","DOI":"10.1002\/9781118922798.ch40"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/evj.12502","article-title":"Duration of tetanus immunoglobulin G titres following basic immunisation of horses","volume":"48","author":"Kendall","year":"2016","journal-title":"Equine Vet. J."},{"key":"ref_35","first-page":"307","article-title":"Active tetanus prophylaxis in the horse and the duration of immunity","volume":"112","author":"Radvila","year":"1970","journal-title":"Schweiz. Arch. Fur Tierheilkd."},{"key":"ref_36","first-page":"376","article-title":"Evaluation of an immunochromatographic dipstick test for the assessment of tetanus immunity in horses","volume":"128","author":"Recknagel","year":"2015","journal-title":"Berl. Und Munch. Tierarztl. Wochenschr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1939-1676.1994.tb03210.x","article-title":"Tetanus in the horse: A review of 20 cases (1970 to 1990)","volume":"8","author":"Green","year":"1994","journal-title":"J. Vet. Intern. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/vec.12668","article-title":"Retrospective evaluation of 155 adult equids and 21 foals with tetanus in Western, Northern, and Central Europe (2000\u20132014). Part 1: Description of history and clinical evolution","volume":"27","author":"Saegerman","year":"2017","journal-title":"J. Vet. Emerg. Crit. Care"},{"key":"ref_39","first-page":"211","article-title":"The Immune Response of Horses to Tetanus Toxoid","volume":"46","author":"Jansen","year":"1979","journal-title":"Onderstepoort J. Vet. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1016\/j.vaccine.2010.08.043","article-title":"Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix","volume":"28","author":"Heldens","year":"2010","journal-title":"Vaccine"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1751-0813.1980.tb05647.x","article-title":"Combined active-passive immunisation of horses against tetanus","volume":"56","author":"Liefman","year":"1980","journal-title":"Aust. Vet. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2460\/javma.249.4.411","article-title":"Duration of serum antibody response to rabies vaccination in horses","volume":"249","author":"Harvey","year":"2016","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"National Association of State Public Health Veterinarians, Compendium of Animal Rabies Prevention and Control Committee, Brown, C.M., Slavinski, S., Ettestad, P., Sidwa, T.J., and Sorhage, F.E. (2016). Compendium of animal rabies prevention and control, 2016. J. Am. Vet. Med. Assoc., 248, 505\u2013517.","DOI":"10.2460\/javma.248.5.505"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1128\/JVI.72.5.3711-3719.1998","article-title":"Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system","volume":"72","author":"Hooper","year":"1998","journal-title":"J. Virol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1073\/pnas.74.1.334","article-title":"In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus","volume":"74","author":"Wiktor","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1084\/jem.145.6.1617","article-title":"Suppression of cell-mediated immunity by street rabies virus","volume":"145","author":"Wiktor","year":"1977","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/S0264-410X(03)00504-8","article-title":"Rabies DNA vaccine in the horse: Strategies to improve serological responses","volume":"21","author":"Fischer","year":"2003","journal-title":"Vaccine"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2460\/javma.1992.200.08.1133","article-title":"Rabies in horses: 21 cases (1970\u20131990)","volume":"200","author":"Green","year":"1992","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S0264-410X(98)00110-8","article-title":"Neonatal immunity and immunisation in early age: Lessons from veterinary medicine","volume":"16","author":"Chappuis","year":"1998","journal-title":"Vaccine"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/evj.12829","article-title":"The challenges posed by equine arboviruses","volume":"50","author":"Chapman","year":"2018","journal-title":"Equine Vet. J."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1128\/CVI.00302-15","article-title":"Evaluation of cross-protection of a lineage 1 West Nile virus inactivated vaccine against natural infections from a virulent lineage 2 strain in horses, under field conditions","volume":"22","author":"Chaintoutis","year":"2015","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"110087","DOI":"10.1016\/j.vetimm.2020.110087","article-title":"Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area","volume":"227","author":"Bakonyi","year":"2020","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1016\/j.vaccine.2011.04.058","article-title":"Protection provided by a recombinant ALVAC\u00ae-WNV vaccine expressing the prM\/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain","volume":"29","author":"Minke","year":"2011","journal-title":"Vaccine"},{"key":"ref_54","first-page":"242","article-title":"Serologic responses to eastern and western equine encephalomyelitis vaccination in previously vaccinated horses","volume":"4","author":"Waldridge","year":"2003","journal-title":"Vet. Ther. Res. Appl. Vet. Med."},{"key":"ref_55","unstructured":"Gibbs, E.P.J., Wilson, J.H., and All, B. (1988). Studies on passive immunity and the vaccination of foals against eastern equine encephalitis in Florida. Proceedings of Equine Infectious Diseases V: Proceedings of the 5th International Conference, The University Press of Kentucky."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/am.26.4.485-488.1973","article-title":"Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to eastern or western equine encephalitis virus, or both","volume":"26","author":"Calisher","year":"1973","journal-title":"Appl. Microbiol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetmic.2009.08.023","article-title":"Encephalitic alphaviruses","volume":"140","author":"Zacks","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_58","first-page":"1442","article-title":"Cross-protective immunity between equine encephalomyelitis viruses in equids","volume":"50","author":"Walton","year":"1989","journal-title":"Am. J. Vet. Res."},{"key":"ref_59","first-page":"621","article-title":"Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses","volume":"39","author":"Barber","year":"1978","journal-title":"Am. J. Vet. Res."},{"key":"ref_60","first-page":"5","article-title":"Studies on immunity to alphaviruses in foals","volume":"40","author":"Ferguson","year":"1979","journal-title":"Am. J. Vet. Res."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"92","DOI":"10.2460\/ajvr.76.1.92","article-title":"West Nile virus\u2013specific immunoglobulin isotype responses in vaccinated and infected horses","volume":"76","author":"Khatibzadeh","year":"2015","journal-title":"Am. J. Vet. Res."},{"key":"ref_62","first-page":"249","article-title":"Evaluation of the efficacy provided by a recombinant canarypox-vectored equine West Nile virus vaccine against an experimental West Nile virus intrathecal challenge in horses","volume":"7","author":"Siger","year":"2006","journal-title":"Vet. Ther."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2746\/042516407X217416","article-title":"Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model","volume":"39","author":"Long","year":"2007","journal-title":"Equine Vet. J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2460\/ajvr.2004.65.1459","article-title":"Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses","volume":"65","author":"Siger","year":"2004","journal-title":"Am. J. Vet. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2460\/javma.2005.226.240","article-title":"Immunologic responses to West Nile virus in vaccinated and clinically affected horses","volume":"226","author":"Davidson","year":"2005","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_66","first-page":"221","article-title":"Equine vaccine for West Nile virus","volume":"114","author":"Ng","year":"2003","journal-title":"Dev. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1939-1676.2006.tb02904.x","article-title":"Diagnostic performance of the equine IgM capture ELISA for serodiagnosis of West Nile virus infection","volume":"20","author":"Long","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cveq.2014.08.009","article-title":"West Nile virus and equine encephalitis viruses: New perspectives","volume":"30","author":"Long","year":"2014","journal-title":"Vet. Clin. Equine Pract."},{"key":"ref_69","first-page":"397","article-title":"Preliminary data regarding the subclinical exposure rate of horses to West Nile virus during the 2001 Florida enzootic","volume":"49","author":"Long","year":"2003","journal-title":"Proc. Am. Assoc. Equine Pract"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/vr.157.22.711","article-title":"Serosurvey for West Nile virus in horses in southern France","volume":"157","author":"Durand","year":"2005","journal-title":"Vet. Rec."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3201\/eid0903.020531","article-title":"Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases","volume":"9","author":"Roehrig","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1089\/vbz.2010.0094","article-title":"Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: Evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay","volume":"11","author":"Kitai","year":"2011","journal-title":"Vector-Borne Zoonotic Dis."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.2460\/javma.2004.225.1894","article-title":"Evaluation of administration of West Nile virus vaccine to pregnant broodmares","volume":"225","author":"Vest","year":"2004","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"ref_74","first-page":"1045","article-title":"Passive transfer of naturally acquired specific immunity against West Nile Virus to foals in a semi-feral pony herd","volume":"20","author":"Wilkins","year":"2006","journal-title":"J. Vet. Intern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1051\/vetres:2006045","article-title":"Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California","volume":"38","author":"Gardner","year":"2007","journal-title":"Vet. Res."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/jvim.15043","article-title":"Streptococcus equi infections in horses: Guidelines for treatment, control, and prevention of strangles\u2014revised consensus statement","volume":"32","author":"Boyle","year":"2018","journal-title":"J. Vet. Intern. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.tvjl.2011.01.019","article-title":"Vaccination elicits a prominent acute phase response in horses","volume":"191","author":"Andersen","year":"2012","journal-title":"Vet. J."},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Arfuso, F., Giudice, E., Di Pietro, S., Piccione, G., and Giannetto, C. (2021). Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus. Animals, 11.","DOI":"10.3390\/ani11020477"},{"key":"ref_79","unstructured":"Holmes, M., Townsend, H., Hussey, S., Breathnach, C., Barnett, C., Holland, R., and Lunn, D. (2003, January 21\u201325). Immune responses to commercial equine vaccines. Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners, New Orleans, LA, USA."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vetimm.2006.01.010","article-title":"Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus","volume":"111","author":"Holmes","year":"2006","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jevs.2013.04.010","article-title":"Serologic responses of West Nile virus seronegative mature horses to West Nile virus vaccines","volume":"33","author":"Cortese","year":"2013","journal-title":"J. Equine Vet. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Chapuis, R.J., Smith, J.S., French, H.M., Toka, F.N., Peterson, E.W., and Little, E.L. (2021). Nonlinear Mixed-Effect Pharmacokinetic Modeling and Distribution of Doxycycline in Healthy Female Donkeys after Multiple Intragastric Dosing\u2013Preliminary Investigation. Animals, 11.","DOI":"10.3390\/ani11072047"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jevs.2018.02.026","article-title":"Infectious diseases in donkeys and mules: An overview and update","volume":"65","author":"Barrandeguy","year":"2018","journal-title":"J. Equine Vet. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jcpa.2015.01.005","article-title":"The CALLISTO project: A summary","volume":"155","author":"Day","year":"2016","journal-title":"J. Comp. Pathol."}],"container-title":["Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/398\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:32:04Z","timestamp":1760135524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-393X\/10\/3\/398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,4]]},"references-count":84,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["vaccines10030398"],"URL":"https:\/\/doi.org\/10.3390\/vaccines10030398","relation":{},"ISSN":["2076-393X"],"issn-type":[{"value":"2076-393X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,4]]}}}